StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
VPL.BO$32.11-13.10%
Fair $32.11+0.0%

VPL.BO

Vrundavan Plantation Limited

Consumer Defensive / Farm ProductsBSE

$32.11

-4.84 (-13.10%)

Fairly Valued+0.0%Fair Value $32.11Fund rank 26/100 · Data gapFallback financials|
SA 40/C
F-Score: 2/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $-33.2M · quality 60.3/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 18/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

40/100

C

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

12/100

SEC 0%

Latest source: unknownPeriods: 3Warnings: 0unknown: 3
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · VPL.BOLocal privado en este navegador · Vrundavan Plantation Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$199M

P/E

11.1x

↓

EV/EBITDA

8.4x

↓

ROE

7.4%

↑

Gross Margin

38.6%

↑

Debt/Equity

0.12

↓
52-Week Range$32
$30$56

TradingView lightweight chart

VPL.BO price, volumen y niveles de valoración

Último $32.11Periodo -68.4%
Fair value: $32.11

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2025 · 2 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

-13.0%

FCF / Net income

-1.89x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $255.1M · net income $17.6M · FCF $-33.2M

2023-FY → 2025-FY

Gross margin

38.6%— pts

Operating margin

9.7%— pts

Net margin

6.9%— pts

FCF margin

-13.0%— pts
MetricTTM
2025
2024
2023
Income Statement
Revenue$255.1M$255.1M$188.3M—
Net Income$17.6M$17.6M$16.9M—
EBITDA$25.5M$25.5M$25.4M—
EPS2.842.843.80—
Gross Margin38.6%38.6%51.1%—
Operating Margin9.7%9.7%13.4%—
Net Margin6.9%6.9%9.0%—
Balance Sheet
Debt/Equity0.120.12——
Current Ratio2.422.42——
Cash Flow
Free Cash Flow$-33.2M$-33.2M$-182.3M$-70000.00
Returns
ROE7.4%7.4%8.1%—
Valuation
P/E11.0711.0714.21—
EV/EBITDA8.418.419.17—
P/B0.830.831.15—
Growth & Yield
Revenue Growth35.5%35.5%——
EPS Growth-25.3%-25.3%——

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

0.1%

fácil

EPS terminal req.

$2.85

Spread vs growth

-25.4%

5Y implied EPS CAGR

4.0%

fácil

EPS terminal req.

$3.45

Spread vs growth

-29.2%

10Y implied EPS CAGR

6.9%

razonable

EPS terminal req.

$5.55

Spread vs growth

-32.2%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -40.6%

Total return

-40.6%

Start / end P/E

14.2x → 11.3x

EPS bridge

3.80 → 2.84

Residual

+5.2%

EPS growth-25.3%
Multiple rerating-20.6%
Dividend+0.0%
Residual / FX / buybacks / cross-term+5.2%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.